A research team from the University of Barcelona (UB) is taking part in a consortium to develop new therapeutic targets for diseases of the central nervous system, such as neurodegenerative pathologie...
Read moreResults of the first-in-human phase I trial of OMO-103 demonstrate its safety and promising anti-tumor activity and shows how this MYC inhibitor can stabilize or even reduce disease burden in some hea...
Read moreResearchers are taking part in a new project with an innovative approach based on immunotherapy to treat serious infections that do not respond to antimicrobials.
Read moreThe Phase IIa study will evaluate the efficacy of CTH120 as an innovative therapy in adult patients with FXS, the most common form of inherited intellectual disability without a specific treatment
Read moreIt has been developed a bioinformatics tool for estimating the genetic risk of suffering common diseases such as diabetes, heart attacks or cancer in a certain population.
Read moreHan demostrado en un estudio realizado con ratones que el tipo de grasas incluido en la dieta modula el comportamiento de los enterococos, un microorganismo frecuente en el tracto digestivo. Los resul...
Read moreThis technology makes it possible to evaluate the efficacy of drugs in biological models that represent at the microscale the conditions under which a tumor develops in the human body.
Read moreEl Instituto de Investigación Sanitaria La Fe (IIS La Fe) ha puesto en marcha un ensayo clínico para mejorar la supervivencia de pacientes diagnosticados con neuroblastoma de alto riesgo en España ...
Read moreThe new immunotherapy is based on the so-called STAb cells. It has yet to pass clinical trials and therefore it will be at least two years before it reaches the patients.
Read moreLa investigación de la URV, enmarcada en un proyecto que estudia los hongos como indicadores de calidad ambiental, remarca que en periodos de sequía algunas especies podrían quedar más expuestas y...
Read moreLos científicos han identificado un ARN, al que han denominado lncREST (long non-coding RNA REplication STress), y han desvelado su papel en la activación de una respuesta efectiva al estrés induci...
Read moreAn international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer after CAR T-cell therapy.
Read more